Tirzepatide 20mg
Full-cycle dual-agonist supply.
Reply within 24 hours.
Important — Research framing
For research purposes only. Not approved for human use outside prescribed medical contexts. Consult a qualified physician before initiating any injectable peptide protocol.
Mechanism
How it works.
Dual GIP/GLP-1 receptor activation — the most clinically studied incretin-based peptide for metabolic and body composition research.
20mg vial — full 8–10 week supply at standard protocol doses. Most cost-effective entry point for a complete Tirzepatide research cycle.
Research protocol
Titration schedule.
Reference titration based on published research protocols. We confirm your specific protocol fit in chat before fulfilment.
- Week 1–20.5mg
Starting dose.
- Week 3–41.0mg
- Week 5–61.5–2.0mg
- Week 7+2.0–2.5mg
Maintenance. Higher titration via consultation.
Order
Start Tirzepatide 20mg.
Message us on Telegram. We'll confirm fit, walk through the titration, and ship within 24 hours.